John Alexander Bartlett
Professor of Medicine
My clinical investigation is focused on the pathogenesis and treatment of HIV infection and its complicastions, especially in resource-limited settings.
Key Words: HIV infection, AIDS, treatment strategies, treatment failure, co-infections, resource-limited settings
Key Words: HIV infection, AIDS, treatment strategies, treatment failure, co-infections, resource-limited settings
Current Appointments & Affiliations
- Professor of Medicine, Medicine, Infectious Diseases, Medicine 2001
- Director of the AIDS Research and Treatment Center, Medicine, Clinical Science Departments 1992
- Professor in the School of Nursing, School of Nursing, Duke University 2004
- Research Professor of Global Health, Duke Global Health Institute, University Institutes and Centers 2011
- Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2013
- Affiliate of the Duke Initiative for Science & Society, Duke Science & Society, Initiatives 2014
Contact Information
- 235 Trent Hall, Durham, NC 27710
- Duke Box 90519, Durham, NC 27710
-
bartl004@duke.edu
(919) 681-8043
- Background
-
Education, Training, & Certifications
- Fellow in Infectious Diseases, Medicine, Duke University 1985 - 1987
- Medical Resident, Medicine, Duke University 1981 - 1984
- M.D., University of Virginia 1981
-
Duke Appointment History
- Associate Professor of Medicine, Medicine, Infectious Diseases, Medicine 1996 - 2001
- Assistant Professor of Medicine, Medicine, Infectious Diseases, Medicine 1989 - 1996
- Recognition
-
In the News
-
OCT 16, 2020 -
MAY 30, 2019 Duke Global Health Institute -
NOV 9, 2015 Newsweek -
FEB 6, 2015 -
NOV 20, 2014 -
FEB 3, 2014 -
JAN 30, 2014 Durham Herald-Sun -
JAN 13, 2014 -
DEC 4, 2013
-
- Expertise
-
Global Scholarship
-
Expertise
-
Research
-
- Research
-
Selected Grants
- Developing an intervention to improve quality of myocardial infarction care in northern Tanzania awarded by National Institutes of Health 2021 - 2026
- Interdisciplinary Research Training Program in AIDS awarded by National Institutes of Health 2010 - 2025
- PRACT: A Pragmatic Randomized Adaptive Clinical Trial to Investigate Controlling Alcohol related harms in a Low-Income Setting; Emergency Department Brief Interventions in Tanzania awarded by National Institutes of Health 2020 - 2025
- Social support to retain adolescents living with HIV in care and improve ART adherence awarded by National Institutes of Health 2019 - 2024
- Partnership to establish a practice based network to assess for head and neck cancers using a low-cost portable flexible nasopharyngoscope awarded by National Institutes of Health 2019 - 2024
- Duke CTSA (TL1) awarded by National Institutes of Health 2018 - 2023
- Sociobehavioral Sciences Research to Improve Care for HIV Infection in Tanzania awarded by National Institutes of Health 2013 - 2023
- NIAID Virology Quality Assurance - Option 1 awarded by National Institutes of Health 2019 - 2021
- Mid Southern Primary Care Networks Node awarded by National Institutes of Health 2015 - 2021
- RAPID: Poirot: From Contact Tracing to Private Exposure Detection awarded by National Science Foundation 2020 - 2021
- Ryan White HIV Adult ID Services, Year 3 awarded by Wake County Human Services 2018 - 2021
- The Aga Khan University-Pakistan Initiative for NCDs (AKUPI-NCDs) awarded by Aga Khan University 2019 - 2020
- Strengthening of Research Capacity for Junior Faculty in Tanzania awarded by Kilimanjaro Christian Medical Centre 2015 - 2020
- Community and physician perceptions of chest pain and prevalence of ischemic ECG features among emergency department patients in Moshi, Tanzania awarded by Vanderbilt University Medical Center 2018 - 2020
- Addressing High Risk Alcohol Use Amongst Injury Patients in an Emergency Department in Tanzania awarded by National Institutes of Health 2015 - 2020
- Integrating Mental Health into HIV Clinic to Improve Outcomes in Tanzanian Youth awarded by National Institutes of Health 2015 - 2020
- Cancer Treatment Disparities in the HIV Population: Exploring the Impact of HIV on Physician and Patient Decision-Making awarded by National Institutes of Health 2018 - 2019
- Ryan White HIV Adult ID Services, Year 9 awarded by Wake County Human Services 2017 - 2018
- Institutional Training Grant in Pediatric Infectious Disease awarded by National Institutes of Health 2011 - 2016
- HIV and Asthma in the Post- ART Era awarded by National Institutes of Health 2014 - 2016
- KCM College-Duke Medical Educational Partnership (DUKE) awarded by Kilimanjaro Christian Medical Centre 2010 - 2016
- Ryan White HIV Adult ID Services, Year 7 awarded by Wake County Human Services 2015 - 2016
- Risk Factors for Atherosclerosis among Patients with Heart Failure in Kenya awarded by National Institutes of Health 2011 - 2015
- Developing Research Capacity in Africa for Studies on HIV-Associated Malignancies (D43) awarded by National Institutes of Health 2010 - 2015
- 5UM1-AI069484-07 Supplement awarded by National Institutes of Health 2007 - 2014
- HIV/AIDS Clinical Trials Unit and Research Sites awarded by National Institutes of Health 2007 - 2014
- AIDS International Training and Research Program awarded by National Institutes of Health 2003 - 2014
- Pregnancy and Response to Antiretroviral Therapy in South Africa awarded by National Institutes of Health 2010 - 2013
- Fatigue in HIV Positive People awarded by National Institutes of Health 2004 - 2010
- International Clinical Trials Unit awarded by National Institutes of Health 2004 - 2009
- The Role of Virus Recombination in Multiple Drug Resistance awarded by National Institutes of Health 2003 - 2008
- HIV/AIDS Clinical Trials Unit (IMPAACT CTU) awarded by National Institutes of Health 2007 - 2008
- IMPAACT CTU awarded by National Institutes of Health 2007 - 2008
- K24 Mid-career Clinical Investigator Award awarded by National Institutes of Health 2000 - 2007
- Early Intervention Services with Respect to HIV Disease in the Northern Outreach Clinic awarded by Health Resources and Service Administration (HRSA) 2000 - 2007
- Adult AIDS Clinical Trials Unit awarded by National Institutes of Health 1996 - 2006
- Adult AIDS Clinical Trials Unit (Administrative Supplement 2) awarded by National Institutes of Health 1996 - 2006
- (PETS) Peer Training to Empower, Education and Advocate awarded by Department of Health and Human Services 2002 - 2005
- Positive Connections - A peer Prevention Program and RAP - Resist all pressure: A peer Intervention Program for At-risk awarded by Department of Health and Human Services 2002 - 2005
- Adult Aids Clinical Trials Unit awarded by National Institutes of Health 1996 - 2004
- same awarded by National Institutes of Health 1996 - 2003
- Aids Research awarded by National Institutes of Health 1989 - 2002
- Same awarded by National Institutes of Health 1996 - 2000
- Adult Aids Clinical Trials Unit awarded by National Institutes of Health 1996 - 1999
- Duke University Adult Aids Clinical Trails Unit awarded by National Institutes of Health 1996 - 1999
- Viral Control And Immune Reconstitution In Hiv Infection awarded by National Institutes of Health 1996 - 1999
- Viral Control & Immune Reconstitution In Hiv Infection awarded by National Institutes of Health 1995 - 1999
- Effect Of Medications On Taste And Smell In Hiv awarded by National Institutes of Health 1996 - 1999
- Duke University Center For Aids Research awarded by National Institutes of Health 1994 - 1999
- General Clinical Research Center (Cru) awarded by National Institutes of Health 1975 - 1998
- Adoptive Immunotherapy For Aids Lymphoma awarded by National Institutes of Health 1993 - 1996
- Duke University Center For Aids Research awarded by National Institutes of Health 1993 - 1994
- The Establishment Of An Aids Treatment Evaluation Unit awarded by National Institutes of Health 1991
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Balandya, Emmanuel, Bruno Sunguya, Daniel W. Gunda, Benson Kidenya, Tumaini Nyamhanga, Irene K. Minja, Michael Mahande, et al. “Building sustainable research capacity at higher learning institutions in Tanzania through mentoring of the Young Research Peers.” Bmc Medical Education 21, no. 1 (March 17, 2021): 166. https://doi.org/10.1186/s12909-021-02611-0.Full Text
-
Hertz, Julian T., Francis M. Sakita, Godfrey L. Kweka, Gerald S. Bloomfield, John A. Bartlett, Tumsifu G. Tarimo, Gloria Temu, Janet P. Bettger, and Nathan M. Thielman. “Effect of a Triage-Based Screening Protocol on Diagnosis and Treatment of Acute Coronary Syndrome in a Tanzanian Emergency Department: A Prospective Pre-Post Study.” J Am Heart Assoc 9, no. 16 (August 18, 2020): e016501. https://doi.org/10.1161/JAHA.120.016501.Full Text Link to Item
-
Hertz, Julian T., Francis M. Sakita, Godfrey L. Kweka, Alexander T. Limkakeng, Sophie W. Galson, Jinny J. Ye, Tumsifu G. Tarimo, et al. “Acute myocardial infarction under-diagnosis and mortality in a Tanzanian emergency department: A prospective observational study.” Am Heart J 226 (August 2020): 214–21. https://doi.org/10.1016/j.ahj.2020.05.017.Full Text Open Access Copy Link to Item
-
Munishi, Oresto Michael, Valerie McCormack, Bariki Mchome, Glory Mangi, Leah L. Zullig, John Bartlett, Oscar Mapunda, et al. “Awareness of Cancer Risk Factors and Its Signs and Symptoms in Northern Tanzania: a Cross-Sectional Survey in the General Population and in People Living with HIV.” J Cancer Educ 35, no. 4 (August 2020): 696–704. https://doi.org/10.1007/s13187-019-01513-6.Full Text Link to Item
-
Irira, Michael, James S. Ngocho, Joshua Youze, Irene Shayo, Venancia Komba, Linda Minja, Francis P. Karia, John Bartlett, and Blandina T. Mmbaga. “Prevalence and Outcome of HIV-associated Malignancies Among HIV-infected Children Enrolled into Care at Kilimanjaro Christian Medical Center 2006 to 2014: A Hospital-based Retrospective Analytical Study.” J Pediatr Hematol Oncol 42, no. 1 (January 2020): 69–73. https://doi.org/10.1097/MPH.0000000000001389.Full Text Link to Item
-
Mremi, Alex, Jackline Mswima, Mathew G. Mlay, Henry Bartholomew, Julius P. Alloyce, Blandina T. Mmbaga, and John Bartlett. “Cancer spectrum in HIV-infected patients: A zonal hospital experience in Tanzania.” Cancer Treat Res Commun 25 (2020): 100213. https://doi.org/10.1016/j.ctarc.2020.100213.Full Text Link to Item
-
Hertz, Julian T., Francis M. Sakita, Alexander T. Limkakeng, Blandina T. Mmbaga, Lambert T. Appiah, John A. Bartlett, and Sophie W. Galson. “The burden of acute coronary syndrome, heart failure, and stroke among emergency department admissions in Tanzania: A retrospective observational study.” Afr J Emerg Med 9, no. 4 (December 2019): 180–84. https://doi.org/10.1016/j.afjem.2019.07.001.Full Text Open Access Copy Link to Item
-
Muiruri, Charles, Scholastica J. Swai, Habib O. Ramadhani, Brandon A. Knettel, Michael J. Mahande, Sia E. Msuya, and John A. Bartlett. “Individual and partner characteristics associated with HIV testing and counseling uptake among individuals 50 years or older in Tanzania.” Int J Std Aids 30, no. 14 (December 2019): 1425–31. https://doi.org/10.1177/0956462419874990.Full Text Link to Item
-
Msoka, Titus F., Gary P. Van Guilder, Marceline van Furth, Yvo Smulders, Sebastian J. Meek, John A. Bartlett, Joao Ricardo N. Vissoci, and Michiel A. van Agtmael. “The effect of HIV infection, antiretroviral therapy on carotid intima-media thickness: A systematic review and meta-analysis.” Life Sci 235 (October 15, 2019): 116851. https://doi.org/10.1016/j.lfs.2019.116851.Full Text Link to Item
-
Corrigan, Kelsey L., Kevin C. Wall, John A. Bartlett, and Gita Suneja. “Cancer disparities in people with HIV: A systematic review of screening for non-AIDS-defining malignancies.” Cancer 125, no. 6 (March 15, 2019): 843–53. https://doi.org/10.1002/cncr.31838.Full Text Link to Item
-
Msoka, Titus F., Gary P. Van Guilder, Yvo M. Smulders, Marceline van Furth, John A. Bartlett, and Michiel A. van Agtmael. “Correction to: Association of HIV-infection, antiretroviral treatment and metabolic syndrome with large artery stiffness: a cross-sectional study.” Bmc Infect Dis 19, no. 1 (February 22, 2019): 187. https://doi.org/10.1186/s12879-019-3728-6.Full Text Link to Item
-
Msoka, Titus F., Gary P. Van Guilder, Yvo M. Smulders, Marceline van Furth, John A. Bartlett, and Michiel A. van Agtmael. “Association of HIV-infection, antiretroviral treatment and metabolic syndrome with large artery stiffness: a cross-sectional study.” Bmc Infect Dis 18, no. 1 (December 29, 2018): 708. https://doi.org/10.1186/s12879-018-3637-0.Full Text Link to Item
-
Ramadhani, Habib O., Charles Muiruri, Venance P. Maro, Balthazar Nyombi, Michael Omondi, Julian B. Mushi, Eileen S. Lirhunde, and John A. Bartlett. “Patient-Initiated Repackaging of Antiretroviral Therapy, Viral Suppression and Drug Resistance.” Aids Behav 22, no. 5 (May 2018): 1671–78. https://doi.org/10.1007/s10461-017-1721-x.Full Text Link to Item
-
Tarimo, Chrispina N., Gibson E. Kapanda, Charles Muiruri, Ahaz T. Kulanga, Esther Lisasi, Kien A. Mteta, Egbert Kessi, et al. “Building Clinical Clerkships Capacity in a Resource-limited Setting: The Case of the Kilimanjaro Christian Medical University College in Tanzania.” Ann Glob Health 84, no. 1 (April 30, 2018): 129–38. https://doi.org/10.29024/aogh.15.Full Text Link to Item
-
Dow, Dorothy E., Werner Schimana, Balthazar M. Nyombi, Blandina T. Mmbaga, Aisa M. Shayo, John A. Bartlett, Charles G. Massambu, et al. “HIV Resistance and Prevention of Mother-to-Child Transmission Regimen in HIV-Infected Infants in Northern Tanzania.” Aids Res Hum Retroviruses 33, no. 11 (November 2017): 1107–13. https://doi.org/10.1089/AID.2017.0025.Full Text Link to Item
-
Bartlett, John A., Sarah Cao, Blandina Mmbaga, Xu Qian, Michael Merson, and Randall Kramer. “Partnership Conference.” Ann Glob Health 83, no. 3–4 (May 2017): 630–36. https://doi.org/10.1016/j.aogh.2017.08.002.Full Text Link to Item
-
Matoga, Mitch M., Mina C. Hosseinipour, Evgenia Aga, Heather J. Ribaudo, Nagalingeswaran Kumarasamy, John Bartlett, Michael D. Hughes, and Michael D. ACTG A5230 Study Team. “Hyperlipidaemia in HIV-infected patients on lopinavir/ritonavir monotherapy in resource-limited settings.” Antivir Ther 22, no. 3 (2017): 205–13. https://doi.org/10.3851/IMP3101.Full Text Link to Item
-
Semvua, Seleman Khamis, Catherine Orrell, Blandina Theophil Mmbaga, Hadija Hamis Semvua, John A. Bartlett, and Andrew A. Boulle. “Predictors of non-adherence to antiretroviral therapy among HIV infected patients in northern Tanzania.” Plos One 12, no. 12 (2017): e0189460. https://doi.org/10.1371/journal.pone.0189460.Full Text Link to Item
-
Msoka, T. F., G. P. Van Guilder, Y. M. Smulders, M. van Furth, J. A. Bartlett, and M. A. van Agtmael. “Antiretroviral treatment and time since HIV-1 diagnosis are associated with large artery stiffness in sub-Saharan African HIV-1 patients.” Artery Research 16 (December 1, 2016): 34–41. https://doi.org/10.1016/j.artres.2016.09.002.Full Text
-
Vardhanabhuti, Saran, David Katzenstein, John Bartlett, Nagalingeswaran Kumarasamy, and Carole L. Wallis. “Human Immunodeficiency Virus-1 Sequence Changes and Drug Resistance Mutation Among Virologic Failures of Lopinavir/Ritonavir Monotherapy: AIDS Clinical Trials Group Protocol A5230.” Open Forum Infect Dis 3, no. 3 (September 2016): ofw154. https://doi.org/10.1093/ofid/ofw154.Full Text Link to Item
-
Borges, Álvaro H., Andreas Lundh, Britta Tendal, John A. Bartlett, Nathan Clumeck, Dominique Costagliola, Eric S. Daar, et al. “Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials.” Clin Infect Dis 63, no. 2 (July 15, 2016): 268–80. https://doi.org/10.1093/cid/ciw236.Full Text Link to Item
-
Ramadhani, Habib O., Charles Muiruri, Venance P. Maro, Michael Omondi, Julian B. Mushi, Eileen S. Lirhunde, and John A. Bartlett. “Association of knowledge on ART line of treatment, scarcity of treatment options and adherence.” Bmc Health Serv Res 16 (July 15, 2016): 265. https://doi.org/10.1186/s12913-016-1483-6.Full Text Link to Item
-
Kapanda, Gibson Erick, Charles Muiruri, Ahaz T. Kulanga, Chrispina N. Tarimo, Esther Lisasi, Lucy Mimano, Kien Mteta, and John A. Bartlett. “Enhancing future acceptance of rural placement in Tanzania through peripheral hospital rotations for medical students.” Bmc Med Educ 16 (February 9, 2016): 51. https://doi.org/10.1186/s12909-016-0582-8.Full Text Link to Item
-
Derache, Anne, Carole L. Wallis, Saran Vardhanabhuti, John Bartlett, Nagalingeswaran Kumarasamy, and David Katzenstein. “Phenotype, Genotype, and Drug Resistance in Subtype C HIV-1 Infection.” J Infect Dis 213, no. 2 (January 15, 2016): 250–56. https://doi.org/10.1093/infdis/jiv383.Full Text Link to Item
-
Ramadhani, Habib O., John A. Bartlett, Nathan M. Thielman, Brian W. Pence, Stephen M. Kimani, Venance P. Maro, Mtumwa S. Mwako, et al. “The Effect of Switching to Second-Line Antiretroviral Therapy on the Risk of Opportunistic Infections Among Patients Infected With Human Immunodeficiency Virus in Northern Tanzania.” Open Forum Infect Dis 3, no. 1 (January 2016): ofw018. https://doi.org/10.1093/ofid/ofw018.Full Text Link to Item
-
Kumarasamy, Nagalingeswaran, Evgenia Aga, Heather J. Ribaudo, Carole L. Wallis, David A. Katzenstein, Wendy S. Stevens, Michael R. Norton, et al. “Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230.” Clin Infect Dis 60, no. 10 (May 15, 2015): 1552–58. https://doi.org/10.1093/cid/civ109.Full Text Open Access Copy Link to Item
-
Rubach, Matthew P., Venance P. Maro, John A. Bartlett, and John A. Crump. “Etiologies of illness among patients meeting integrated management of adolescent and adult illness district clinician manual criteria for severe infections in northern Tanzania: implications for empiric antimicrobial therapy.” Am J Trop Med Hyg 92, no. 2 (February 2015): 454–62. https://doi.org/10.4269/ajtmh.14-0496.Full Text Open Access Copy Link to Item
-
Mavura, Daudi R., E John Masenga, Eli Minja, Henning Grossmann, John A. Crump, and John A. Bartlett. “Initiation of antiretroviral therapy in HIV-infected adults with skin complaints in northern Tanzania.” Int J Dermatol 54, no. 1 (January 2015): 68–73. https://doi.org/10.1111/ijd.12563.Full Text Open Access Copy Link to Item
-
Vidal, Adriana C., David Skaar, Rachel Maguire, Seyram Dodor, Laura W. Musselwhite, John A. Bartlett, Olola Oneko, et al. “IL-10, IL-15, IL-17, and GMCSF levels in cervical cancer tissue of Tanzanian women infected with HPV16/18 vs. non-HPV16/18 genotypes.” Infect Agent Cancer 10 (2015): 10. https://doi.org/10.1186/s13027-015-0005-1.Full Text Open Access Copy Link to Item
-
Dow, Dorothy E., and John A. Bartlett. “Dolutegravir, the Second-Generation of Integrase Strand Transfer Inhibitors (INSTIs) for the Treatment of HIV.” Infect Dis Ther 3, no. 2 (December 2014): 83–102. https://doi.org/10.1007/s40121-014-0029-7.Full Text Link to Item
-
Ramadhani, Habib O., John A. Bartlett, Nathan M. Thielman, Brian W. Pence, Stephen M. Kimani, Venance P. Maro, Mtumwa S. Mwako, et al. “Association of first-line and second-line antiretroviral therapy adherence.” Open Forum Infect Dis 1, no. 2 (September 2014): ofu079. https://doi.org/10.1093/ofid/ofu079.Full Text Link to Item
-
Wallis, Carole L., Evgenia Aga, Heather Ribaudo, Shanmugam Saravanan, Michael Norton, Wendy Stevens, Nagalingeswaran Kumarasamy, John Bartlett, David Katzenstein, and David A5230 team. “Drug susceptibility and resistance mutations after first-line failure in resource limited settings.” Clin Infect Dis 59, no. 5 (September 1, 2014): 706–15. https://doi.org/10.1093/cid/ciu314.Full Text Link to Item
-
Lisasi, Esther, Ahaz Kulanga, Charles Muiruri, Lucy Killewo, Ndimangwa Fadhili, Lucy Mimano, Gibson Kapanda, et al. “Modernizing and transforming medical education at the Kilimanjaro Christian Medical University College.” Acad Med 89, no. 8 Suppl (August 2014): S60–64. https://doi.org/10.1097/ACM.0000000000000327.Full Text Link to Item
-
Bartz, Sarah, Aaloke Mody, Christoph Hornik, James Bain, Michael Muehlbauer, Tonny Kiyimba, Elizabeth Kiboneka, et al. “Severe acute malnutrition in childhood: hormonal and metabolic status at presentation, response to treatment, and predictors of mortality.” J Clin Endocrinol Metab 99, no. 6 (June 2014): 2128–37. https://doi.org/10.1210/jc.2013-4018.Full Text Link to Item
-
De Boer, C., N. Niyonzima, J. Orem, J. Bartlett, and S. Y. Zafar. “Prognosis and delay of diagnosis among Kaposi's sarcoma patients in Uganda: A cross-sectional study.” Infectious Agents and Cancer 9, no. 1 (May 20, 2014). https://doi.org/10.1186/1750-9378-9-17.Full Text
-
Nyindo, Mramba, Jovin Kitau, Esther Lisasi, Gibson Kapanda, Johnston Matowo, Patrick Francis, and John Bartlett. “Introduction of team-based learning (TBL) at Kilimanjaro Christian Medical University College: experience with the ectoparasites module.” Med Teach 36, no. 4 (April 2014): 308–13. https://doi.org/10.3109/0142159X.2013.876490.Full Text Link to Item
-
Vidal, A. C., N. M. Henry, S. K. Murphy, O. Oneko, M. Nye, J. A. Bartlett, F. Overcash, et al. “PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer.” Clinical and Translational Oncology 16, no. 3 (March 1, 2014): 266–72. https://doi.org/10.1007/s12094-013-1067-4.Full Text
-
Vidal, A. C., N. M. Henry, S. K. Murphy, O. Oneko, M. Nye, J. A. Bartlett, F. Overcash, et al. “PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer.” Clin Transl Oncol 16, no. 3 (March 2014): 266–72. https://doi.org/10.1007/s12094-013-1067-4.Full Text Link to Item
-
Reddy, E. A., B. N. Njau, S. C. Morpeth, K. E. Lancaster, A. C. Tribble, V. P. Maro, L. J. Msuya, et al. “A randomized controlled trial of standard versus intensified tuberculosis diagnostics on treatment decisions by physicians in Northern Tanzania.” Bmc Infectious Diseases 14, no. 1 (February 20, 2014). https://doi.org/10.1186/1471-2334-14-89.Full Text
-
Reddy, Elizabeth A., Boniface N. Njau, Susan C. Morpeth, Kathryn E. Lancaster, Alison C. Tribble, Venance P. Maro, Levina J. Msuya, et al. “A randomized controlled trial of standard versus intensified tuberculosis diagnostics on treatment decisions by physicians in Northern Tanzania.” Bmc Infect Dis 14 (February 20, 2014): 89. https://doi.org/10.1186/1471-2334-14-89.Full Text Open Access Copy Link to Item
-
Buchanan, Ann M., Dorothy E. Dow, Charles G. Massambu, Balthazar Nyombi, Aisa Shayo, Rahma Musoke, Sheng Feng, John A. Bartlett, Coleen K. Cunningham, and Werner Schimana. “Progress in the prevention of mother to child transmission of HIV in three regions of Tanzania: a retrospective analysis.” Plos One 9, no. 2 (2014): e88679. https://doi.org/10.1371/journal.pone.0088679.Full Text Link to Item
-
Harmon, James L., Michelle Collins-Ogle, John A. Bartlett, Julie Thompson, and Julie Barroso. “Integrating routine HIV screening into a primary care setting in rural North Carolina.” J Assoc Nurses Aids Care 25, no. 1 (January 2014): 70–82. https://doi.org/10.1016/j.jana.2013.01.001.Full Text Link to Item
-
Mody, Aaloke, Sarah Bartz, Christoph P. Hornik, Tonny Kiyimba, James Bain, Michael Muehlbauer, Elizabeth Kiboneka, et al. “Effects of HIV infection on the metabolic and hormonal status of children with severe acute malnutrition.” Plos One 9, no. 7 (2014): e102233. https://doi.org/10.1371/journal.pone.0102233.Full Text Link to Item
-
Vidal, A. C., N. M. Henry, S. K. Murphy, O. Oneko, M. Nye, J. A. Bartlett, F. Overcash, et al. “PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer.” Clinical and Translational Oncology 16, no. 3 (2014): 266–72.
-
Zullig, Leah L., Sky B. Vanderburg, Charles Muiruri, Amy Abernethy, Bryan J. Weiner, and John Bartlett. “Sustainability of cancer registration in the Kilimanjaro Region of Tanzania--a qualitative assessment.” World Health Popul 15, no. 1 (2014): 21–30. https://doi.org/10.12927/whp.2014.23721.Full Text Link to Item
-
Fiorillo, S. P., H. C. Diefenthal, P. C. Goodman, H. O. Ramadhani, B. N. Njau, A. B. Morrissey, V. P. Maro, et al. “Chest radiography for predicting the cause of febrile illness among inpatients in Moshi, Tanzania.” Clin Radiol 68, no. 10 (October 2013): 1039–46. https://doi.org/10.1016/j.crad.2013.05.002.Full Text Link to Item
-
Bartlett, John A. “Lack of protease inhibitor resistance following treatment failure--too good to be true?” J Clin Invest 123, no. 9 (September 2013): 3704–5. https://doi.org/10.1172/JCI71784.Full Text Link to Item
-
Phillips, Elizabeth, John A. Bartlett, Ian Sanne, Michael M. Lederman, John Hinkle, Franck Rousseau, David Dunn, et al. “Associations between HLA-DRB1*0102, HLA-B*5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa.” J Acquir Immune Defic Syndr 62, no. 2 (February 1, 2013): e55–57. https://doi.org/10.1097/QAI.0b013e31827ca50f.Full Text Link to Item
-
Crump, John A., Anne B. Morrissey, William L. Nicholson, Robert F. Massung, Robyn A. Stoddard, Renee L. Galloway, Eng Eong Ooi, et al. “Etiology of severe non-malaria febrile illness in Northern Tanzania: a prospective cohort study.” Plos Negl Trop Dis 7, no. 7 (2013): e2324. https://doi.org/10.1371/journal.pntd.0002324.Full Text Open Access Copy Link to Item
-
Nye, Monica D., Cathrine Hoyo, Zhiqing Huang, Adriana C. Vidal, Frances Wang, Francine Overcash, Jennifer S. Smith, et al. “Associations between methylation of paternally expressed gene 3 (PEG3), cervical intraepithelial neoplasia and invasive cervical cancer.” Plos One 8, no. 2 (2013): e56325. https://doi.org/10.1371/journal.pone.0056325.Full Text Link to Item
-
Zullig, Leah L., Charles Muiruri, Amy Abernethy, Bryan J. Weiner, John Bartlett, Olola Oneko, and S Yousuf Zafar. “Cancer registration needs assessment at a tertiary medical centre in Kilimanjaro, Tanzania.” World Health Popul 14, no. 2 (2013): 12–23. https://doi.org/10.12927/whp.2013.23271.Full Text Link to Item
-
Bouley, Andrew J., Holly M. Biggs, Robyn A. Stoddard, Anne B. Morrissey, John A. Bartlett, Isaac A. Afwamba, Venance P. Maro, et al. “Brucellosis among hospitalized febrile patients in northern Tanzania.” Am J Trop Med Hyg 87, no. 6 (December 2012): 1105–11. https://doi.org/10.4269/ajtmh.2012.12-0327.Full Text Open Access Copy Link to Item
-
Bartlett, John A., Heather J. Ribaudo, Carole L. Wallis, Evgenia Aga, David A. Katzenstein, Wendy S. Stevens, Michael R. Norton, et al. “Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings.” Aids 26, no. 11 (July 17, 2012): 1345–54. https://doi.org/10.1097/QAD.0b013e328353b066.Full Text Open Access Copy Link to Item
-
Crump, John A., Habib O. Ramadhani, Anne B. Morrissey, Wilbrod Saganda, Mtumwa S. Mwako, Lan-Yan Yang, Shein-Chung Chow, et al. “Bacteremic disseminated tuberculosis in sub-saharan Africa: a prospective cohort study.” Clin Infect Dis 55, no. 2 (July 2012): 242–50. https://doi.org/10.1093/cid/cis409.Full Text Open Access Copy Link to Item
-
Hertz, Julian T., O Michael Munishi, Eng Eong Ooi, Shiqin Howe, Wen Yan Lim, Angelia Chow, Anne B. Morrissey, et al. “Chikungunya and dengue fever among hospitalized febrile patients in northern Tanzania.” Am J Trop Med Hyg 86, no. 1 (January 2012): 171–77. https://doi.org/10.4269/ajtmh.2012.11-0393.Full Text Open Access Copy Link to Item
-
Vidal, Adriana C., Susan K. Murphy, Brenda Y. Hernandez, Brandi Vasquez, John A. Bartlett, Olola Oneko, Pendo Mlay, et al. “Distribution of HPV genotypes in cervical intraepithelial lesions and cervical cancer in Tanzanian women.” Infect Agent Cancer 6, no. 1 (November 14, 2011): 20. https://doi.org/10.1186/1750-9378-6-20.Full Text Open Access Copy Link to Item
-
Biggs, Holly M., Duy M. Bui, Renee L. Galloway, Robyn A. Stoddard, Sean V. Shadomy, Anne B. Morrissey, John A. Bartlett, et al. “Leptospirosis among hospitalized febrile patients in northern Tanzania.” Am J Trop Med Hyg 85, no. 2 (August 2011): 275–81. https://doi.org/10.4269/ajtmh.2011.11-0176.Full Text Open Access Copy Link to Item
-
Prabhu, Malavika, William L. Nicholson, Aubree J. Roche, Gilbert J. Kersh, Kelly A. Fitzpatrick, Lindsay D. Oliver, Robert F. Massung, et al. “Q fever, spotted fever group, and typhus group rickettsioses among hospitalized febrile patients in northern Tanzania.” Clin Infect Dis 53, no. 4 (August 2011): e8-15. https://doi.org/10.1093/cid/cir411.Full Text Link to Item
-
Crump, John A., Habib O. Ramadhani, Anne B. Morrissey, Levina J. Msuya, Lan-Yan Yang, Shein-Chung Chow, Susan C. Morpeth, et al. “Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected children and infants in northern Tanzania.” Trop Med Int Health 16, no. 7 (July 2011): 830–37. https://doi.org/10.1111/j.1365-3156.2011.02774.x.Full Text Link to Item
-
Waters, Richard C., Jan Ostermann, Travis D. Reeves, Max F. Masnick, Nathan M. Thielman, John A. Bartlett, and John A. Crump. “A cost-effectiveness analysis of alternative HIV retesting strategies in sub-saharan Africa.” J Acquir Immune Defic Syndr 56, no. 5 (April 15, 2011): 443–52. https://doi.org/10.1097/QAI.0b013e3182118f8c.Full Text Link to Item
-
Crump, John A., Habib O. Ramadhani, Anne B. Morrissey, Wilbrod Saganda, Mtumwa S. Mwako, Lan-Yan Yang, Shein-Chung Chow, et al. “Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in northern Tanzania.” Clin Infect Dis 52, no. 3 (February 1, 2011): 341–48. https://doi.org/10.1093/cid/ciq103.Full Text Link to Item
-
Ostermann, Jan, Elizabeth A. Reddy, Meghan M. Shorter, Charles Muiruri, Antipas Mtalo, Dafrosa K. Itemba, Bernard Njau, John A. Bartlett, John A. Crump, and Nathan M. Thielman. “Who tests, who doesn't, and why? Uptake of mobile HIV counseling and testing in the Kilimanjaro Region of Tanzania.” Plos One 6, no. 1 (January 31, 2011): e16488. https://doi.org/10.1371/journal.pone.0016488.Full Text Open Access Copy Link to Item
-
Buchanan, Ann M., Florida J. Muro, Jean Gratz, John A. Crump, Augustine M. Musyoka, Moses W. Sichangi, Anne B. Morrissey, et al. “Establishment of haematological and immunological reference values for healthy Tanzanian children in Kilimanjaro Region.” Trop Med Int Health 15, no. 9 (September 2010): 1011–21. https://doi.org/10.1111/j.1365-3156.2010.02585.x.Full Text Link to Item
-
Emmett, Susan D., Coleen K. Cunningham, Blandina T. Mmbaga, Grace D. Kinabo, Werner Schimana, Mark E. Swai, John A. Bartlett, John A. Crump, and Elizabeth A. Reddy. “Predicting virologic failure among HIV-1-infected children receiving antiretroviral therapy in Tanzania: a cross-sectional study.” J Acquir Immune Defic Syndr 54, no. 4 (August 2010): 368–75. https://doi.org/10.1097/QAI.0b013e3181cf4882.Full Text Open Access Copy Link to Item
-
Szczech, L. A., P. Menezes, E. Byrd Quinlivan, C. van der Horst, J. A. Bartlett, and L. P. Svetkey. “Microalbuminuria predicts overt proteinuria among patients with HIV infection.” Hiv Med 11, no. 7 (August 2010): 419–26. https://doi.org/10.1111/j.1468-1293.2009.00805.x.Full Text Link to Item
-
Lofgren, Sarah M., Wendy S. Stevens, John A. Bartlett, and John A. Crump. “Reply to 'Quantification of HIV-1 RNA on Dried Blood Spots' AIDS 24:475-6.” Aids 24, no. 5 (March 13, 2010): 785–86. https://doi.org/10.1097/QAD.0b013e32833653c5.Full Text Link to Item
-
Bartlett, J. A., and V. P. Maro. “Stavudine in first-line antiretroviral regimens in resource-limited settings: Time for a better solution.” Hiv Therapy 3, no. 2 (December 7, 2009): 109–11. https://doi.org/10.2217/17584310.3.2.109.Full Text
-
Shao, Humphrey J., John A. Crump, Habib O. Ramadhani, Leonard O. Uiso, Sendui Ole-Nguyaine, Andrew M. Moon, Rehema A. Kiwera, et al. “Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in Tanzania.” Aids Res Hum Retroviruses 25, no. 12 (December 2009): 1277–85. https://doi.org/10.1089/aid.2009.0100.Full Text Open Access Copy Link to Item
-
Shorter, Meghan M., Jan Ostermann, John A. Crump, Alison C. Tribble, Dafrosa K. Itemba, Anna Mgonja, Antipas Mtalo, et al. “Characteristics of HIV voluntary counseling and testing clients before and during care and treatment scale-up in Moshi, Tanzania.” J Acquir Immune Defic Syndr 52, no. 5 (December 2009): 648–54. https://doi.org/10.1097/QAI.0b013e3181b31a6a.Full Text Link to Item
-
Lofgren, Sarah M., Anne B. Morrissey, Caroline C. Chevallier, Anangisye I. Malabeja, Sally Edmonds, Ben Amos, David J. Sifuna, et al. “Evaluation of a dried blood spot HIV-1 RNA program for early infant diagnosis and viral load monitoring at rural and remote healthcare facilities.” Aids 23, no. 18 (November 27, 2009): 2459–66. https://doi.org/10.1097/QAD.0b013e328331f702.Full Text Link to Item
-
Bartlett, John A., and John F. Shao. “Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries.” Lancet Infect Dis 9, no. 10 (October 2009): 637–49. https://doi.org/10.1016/S1473-3099(09)70227-0.Full Text Link to Item
-
Tribble, A. C., C. D. Hamilton, J. A. Crump, A. Mgonja, A. Mtalo, E. Ndanu, D. K. Itemba, et al. “Missed opportunities for diagnosis of tuberculosis and human immunodeficiency virus co-infection in Moshi, Tanzania.” Int J Tuberc Lung Dis 13, no. 10 (October 2009): 1260–66.Link to Item
-
Bartlett, John A., John Hornberger, Ashwini Shewade, Menaka Bhor, and Rukmini Rajagopalan. “Obstacles and proposed solutions to effective antiretroviral therapy in resource-limited settings.” J Int Assoc Physicians Aids Care (Chic) 8, no. 4 (July 2009): 253–68. https://doi.org/10.1177/1545109709337745.Full Text Link to Item
-
Tillekeratne, L. G., N. M. Thielman, R. A. Kiwera, H. Y. Chu, L. Kaale, S. C. Morpeth, J. Ostermann, et al. “Morbidity and mortality among a cohort of HIV-infected adults in a programme for community home-based care, in the Kilimanjaro Region of Tanzania (2003-2005).” Ann Trop Med Parasitol 103, no. 3 (April 2009): 263–73. https://doi.org/10.1179/136485909X398203.Full Text Link to Item
-
Tenorio, Allan R., Hongyu Jiang, Yu Zheng, Barbara Bastow, Daniel R. Kuritzkes, John A. Bartlett, Steven G. Deeks, Alan L. Landay, and Sharon A. Riddler. “Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115.” Aids Res Hum Retroviruses 25, no. 2 (February 2009): 135–39. https://doi.org/10.1089/aid.2008.0200.Full Text Link to Item
-
Crump, John A., Jakko van Ingen, Anne B. Morrissey, Martin J. Boeree, Daudi R. Mavura, Britta Swai, Nathan M. Thielman, et al. “Invasive disease caused by nontuberculous mycobacteria, Tanzania.” Emerg Infect Dis 15, no. 1 (January 2009): 53–55. https://doi.org/10.3201/eid1501.081093.Full Text Link to Item
-
Seshadri, C., L. O. Uiso, J. Ostermann, H. Diefenthal, H. J. Shao, H. Y. Chu, D. M. Asmuth, N. M. Thielman, J. A. Bartlett, and J. A. Crump. “Low sensitivity of T-cell based detection of tuberculosis among HIV co-infected Tanzanian in-patients.” East Afr Med J 85, no. 9 (September 2008): 442–49. https://doi.org/10.4314/eamj.v85i9.117085.Full Text Link to Item
-
Landman, Keren Z., Jan Ostermann, John A. Crump, Anna Mgonja, Meghan K. Mayhood, Dafrosa K. Itemba, Alison C. Tribble, et al. “Gender differences in the risk of HIV infection among persons reporting abstinence, monogamy, and multiple sexual partners in northern Tanzania.” Plos One 3, no. 8 (August 27, 2008): e3075. https://doi.org/10.1371/journal.pone.0003075.Full Text Open Access Copy Link to Item
-
Morpeth, Susan C., Nathan M. Thielman, Habib O. Ramadhani, John D. Hamilton, Jan Ostermann, Peter R. Kisenge, Humphrey J. Shao, et al. “Effect of trimethoprim-sulfamethoxazole prophylaxis on antimicrobial resistance of fecal Escherichia coli in HIV-infected patients in Tanzania.” J Acquir Immune Defic Syndr 47, no. 5 (April 15, 2008): 585–91. https://doi.org/10.1097/QAI.0b013e31816856db.Full Text Link to Item
-
Ramadhani, Habib O., Nathan M. Thielman, Keren Z. Landman, Evaline M. Ndosi, Feng Gao, Jennifer L. Kirchherr, Rekha Shah, et al. “Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania.” Clin Infect Dis 45, no. 11 (December 1, 2007): 1492–98. https://doi.org/10.1086/522991.Full Text Link to Item
-
Morpeth, Susan C., John A. Crump, Humphrey J. Shao, Habib O. Ramadhani, Peter R. Kisenge, Cindy A. Moylan, Susanna Naggie, et al. “Predicting CD4 lymphocyte count <200 cells/mm(3) in an HIV type 1-infected African population.” Aids Res Hum Retroviruses 23, no. 10 (October 2007): 1230–36. https://doi.org/10.1089/aid.2007.0053.Full Text Link to Item
-
Bartlett, John A., Shan-Shan Chen, and Joseph B. Quinn. “Comparative efficacy of nucleoside/nucleotide reverse transcriptase inhibitors in combination with efavirenz: results of a systematic overview.” Hiv Clin Trials 8, no. 4 (July 2007): 221–26. https://doi.org/10.1310/hct0804-221.Full Text Link to Item
-
Bartlett, John A., and Eva P. Muro. “Generic and branded drugs for the treatment of people living with HIV/AIDS.” J Int Assoc Physicians Aids Care (Chic) 6, no. 1 (March 2007): 15–23. https://doi.org/10.1177/1545109707299856.Full Text Link to Item
-
Landman, Keren Z., Nathan M. Thielman, Anna Mgonja, Humphrey J. Shao, Dafrosa K. Itemba, Evelyn M. Ndosi, Alison C. Tribble, John F. Shao, John A. Bartlett, and John A. Crump. “Antiretroviral treatment literacy among HIV voluntary counseling and testing clients in Moshi, Tanzania, 2003 to 2005.” J Int Assoc Physicians Aids Care (Chic) 6, no. 1 (March 2007): 24–26. https://doi.org/10.1177/1545109706298479.Full Text Link to Item
-
Cai, F., H. Chen, C. B. Hicks, J. A. Bartlett, J. Zhu, and F. Gao. “Erratum: ProteomeBinders: Planning a European resource of affinity reagents for analysis of the human proteome (Nature Methods (2007) vol. 4 (13-17)).” Nature Methods 4, no. 2 (February 1, 2007): 187. https://doi.org/10.1038/nmeth0207-187a.Full Text
-
Cai, Fangping, Haifeng Chen, Charles B. Hicks, John A. Bartlett, Jun Zhu, and Feng Gao. “Detection of minor drug-resistant populations by parallel allele-specific sequencing.” Nat Methods 4, no. 2 (February 2007): 123–25. https://doi.org/10.1038/nmeth995.Full Text Link to Item
-
Anderson, Albert M. L., Andrzej S. Kosinski, and John A. Bartlett. “Decreasing CD4+ T-cell count during suppressed or low-level viraemia in patients with HIV infection.” Antivir Ther 12, no. 7 (2007): 1041–48.Link to Item
-
Riddler, Sharon A., Hongyu Jiang, Allan Tenorio, Hairong Huang, Daniel R. Kuritzkes, Edward P. Acosta, Alan Landay, et al. “A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS Clinical Trials Group Study A5115.” Antivir Ther 12, no. 4 (2007): 531–41.Link to Item
-
Bartlett, John A., Judy Johnson, Gisela Herrera, Nestor Sosa, Alan Rodriguez, Qiming Liao, Sandy Griffith, David Irlbeck, Mark S. Shaefer, and Mark S. Clinically Significant Long-Term Antiretroviral Sequential Sequencing Study (CLASS) Team. “Long-term results of initial therapy with abacavir and Lamivudine combined with Efavirenz, Amprenavir/Ritonavir, or Stavudine.” J Acquir Immune Defic Syndr 43, no. 3 (November 1, 2006): 284–92. https://doi.org/10.1097/01.qai.0000243092.40490.26.Full Text Link to Item
-
Bartlett, John A., Michael J. Fath, Ralph Demasi, Ashwaq Hermes, Joseph Quinn, Elsa Mondou, and Franck Rousseau. “An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults.” Aids 20, no. 16 (October 24, 2006): 2051–64. https://doi.org/10.1097/01.aids.0000247578.08449.ff.Full Text Link to Item
-
Haas, David W., John A. Bartlett, Janet W. Andersen, Ian Sanne, Grant R. Wilkinson, John Hinkle, Franck Rousseau, et al. “Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaboration.” Clin Infect Dis 43, no. 6 (September 15, 2006): 783–86. https://doi.org/10.1086/507097.Full Text Link to Item
-
Anderson, Albert M. L., and John A. Bartlett. “Changing antiretroviral therapy in the setting of virologic relapse: review of the current literature.” Curr Hiv/Aids Rep 3, no. 2 (July 2006): 79–85. https://doi.org/10.1007/s11904-006-0022-1.Full Text Link to Item
-
Bartlett, John A., Jeffrey J. Buda, Birgitta von Scheele, Josephine A. Mauskopf, E Anne Davis, Robert Elston, Martin S. King, and E Randall Lanier. “Minimizing resistance consequences after virologic failure on initial combination therapy: a systematic overview.” J Acquir Immune Defic Syndr 41, no. 3 (March 2006): 323–31. https://doi.org/10.1097/01.qai.0000197070.69859.f3.Full Text Link to Item
-
Myers, Sarah A., Angelica A. Selim, Margaret A. McDaniel, Russell Hall, Ying Zhang, John A. Bartlett, and Andrea L. True. “A prospective clinical and pathological examination of injection site reactions with the HIV-1 fusion inhibitor enfuvirtide.” Antivir Ther 11, no. 7 (2006): 935–39.Link to Item
-
Thielman, Nathan M., Helen Y. Chu, Jan Ostermann, Dafrosa K. Itemba, Anna Mgonja, Sabina Mtweve, John A. Bartlett, John F. Shao, and John A. Crump. “Cost-effectiveness of free HIV voluntary counseling and testing through a community-based AIDS service organization in Northern Tanzania.” Am J Public Health 96, no. 1 (January 2006): 114–19. https://doi.org/10.2105/AJPH.2004.056796.Full Text Link to Item
-
Anderson, Albert M. L., and John A. Bartlett. “Fixed dose combination abacavir/lamivudine in the treatment of HIV-1 infection.” Expert Rev Anti Infect Ther 3, no. 6 (December 2005): 871–83. https://doi.org/10.1586/14787210.3.6.871.Full Text Link to Item
-
Henry, Keith, John A. Bartlett, Erna Kojic, and Timothy P. Flanigan. “Antiretroviral rounds. A communication conundrum.” Aids Clin Care 17, no. 12 (December 2005): 115–16.Link to Item
-
Chu, H. Y., J. A. Crump, J. Ostermann, R. B. Oenga, D. K. Itemba, A. Mgonja, S. Mtweve, J. A. Bartlett, J. F. Shao, and N. M. Thielman. “Sociodemographic and clinical characteristics of clients presenting for HIV voluntary counselling and testing in Moshi, Tanzania.” Int J Std Aids 16, no. 10 (October 2005): 691–96. https://doi.org/10.1258/095646205774357307.Full Text Link to Item
-
Sempowski, Gregory D., Charles B. Hicks, Joseph J. Eron, John A. Bartlett, Laura P. Hale, Guido Ferrari, Lloyd J. Edwards, Susan Fiscus, and Barton F. Haynes. “Naïve T cells are maintained in the periphery during the first 3 months of acute HIV-1 infection: implications for analysis of thymus function.” J Clin Immunol 25, no. 5 (September 2005): 462–72. https://doi.org/10.1007/s10875-005-5635-4.Full Text Link to Item
-
Leith, Jonathan, Peter Piliero, Stephen Storfer, Douglas Mayers, and Ralf Hinzmann. “Appropriate use of nevirapine for long-term therapy.” J Infect Dis 192, no. 3 (August 1, 2005): 545–46. https://doi.org/10.1086/431606.Full Text Link to Item
-
Sanne, Ian, Herve Mommeja-Marin, John Hinkle, John A. Bartlett, Michael M. Lederman, Gary Maartens, Charles Wakeford, et al. “Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects.” J Infect Dis 191, no. 6 (March 15, 2005): 825–29. https://doi.org/10.1086/428093.Full Text Link to Item
-
Eron, Joseph J., John A. Bartlett, Jorge L. Santana, Nicholas C. Bellos, Judy Johnson, Amy Keller, Daniel R. Kuritzkes, Marty H. St Clair, and Victoria A. Johnson. “Persistent antiretroviral activity of nucleoside analogues after prolonged zidovudine and lamivudine therapy as demonstrated by rapid loss of activity after discontinuation.” J Acquir Immune Defic Syndr 37, no. 5 (December 15, 2004): 1581–83. https://doi.org/10.1097/00126334-200412150-00009.Full Text Link to Item
-
Sha, Beverly E., Michelle Onorato, John A. Bartlett, Ronald J. Bosch, Evgenia Aga, Mostafa Nokta, Elizabeth M. Adams, Xiao-Dong Li, John Eldridge, and Richard B. Pollard. “Safety and immunogenicity of a polyvalent peptide C4-V3 HIV vaccine in conjunction with IL-12.” Aids 18, no. 8 (May 21, 2004): 1203–6. https://doi.org/10.1097/00002030-200405210-00015.Full Text Link to Item
-
Szczech, Lynda Anne, Stephen J. Gange, Charles van der Horst, John A. Bartlett, Mary Young, Mardge H. Cohen, Kathryn Anastos, Preston S. Klassen, and Laura P. Svetkey. “Definition of proteinuria among women with HIV infection.” Kidney Int 65, no. 4 (April 2004): 1519. https://doi.org/10.1111/j.1523-1755.2004.555_2.x.Full Text Link to Item
-
Eron, Joseph J., Roy M. Gulick, John A. Bartlett, Thomas Merigan, Roberto Arduino, J Michael Kilby, Bienvenido Yangco, et al. “Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV.” J Infect Dis 189, no. 6 (March 15, 2004): 1075–83. https://doi.org/10.1086/381707.Full Text Link to Item
-
Ole-Nguyaine, S., J. A. Crump, G. S. Kibiki, K. Kiang, J. Taylor, W. Schimana, J. A. Bartlett, J. F. Shao, J. D. Hamilton, and N. M. Thielman. “HIV-associated morbidity, mortality and diagnostic testing opportunities among inpatients at a referral hospital in northern Tanzania.” Ann Trop Med Parasitol 98, no. 2 (March 2004): 171–79. https://doi.org/10.1179/000349804225003163.Full Text Link to Item
-
Alexander, Thomas H., Gabriel M. Ortiz, Melissa F. Wellons, Andrew Allen, Edward J. Grace, Becky Schweighardt, Jason Brancato, et al. “Changes in CD4+ T-cell differentiation phenotype during structured treatment interruption in patients with chronic HIV-1 infection.” J Acquir Immune Defic Syndr 34, no. 5 (December 15, 2003): 475–81. https://doi.org/10.1097/00126334-200312150-00005.Full Text Link to Item
-
Bartlett, John A., Pablo Tebas, Roland Bassett, Wenzheng Huang, Daniel Kuritzkes, Ronald Reisler, Nancy Loyack, Kellye Robison, and Kellye ACTG A5064 Team. “Early intensification with abacavir in subjects at high risk for incomplete viral suppression.” Antivir Ther 8, no. 4 (August 2003): 361–63.Link to Item
-
Schweighardt, Becky, Gabriel M. Ortiz, Robert M. Grant, Melissa Wellons, G Diego Miralles, Leondios G. Kostrikis, John A. Bartlett, and Douglas F. Nixon. “Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptions.” Aids 16, no. 17 (November 22, 2002): 2342–44. https://doi.org/10.1097/00002030-200211220-00018.Full Text Link to Item
-
Davidson, Michael, Yuan-I Min, Janet T. Holbrook, Mark Van Natta, Thomas C. Quinn, Robert L. Murphy, William Welch, Douglas A. Jabs, Curtis L. Meinert, and Curtis L. Studies of Ocular Complications of AIDS Research Group. “Influence of filgrastim (granulocyte colony-stimulating factor) on human immunodeficiency virus type 1 RNA in patients with cytomegalovirus retinitis.” J Infect Dis 186, no. 7 (October 1, 2002): 1013–18. https://doi.org/10.1086/342956.Full Text Link to Item
-
Bartlett, John A., G Diego Miralles, Anne D. Sevin, Martha Silberman, Scott K. Pruitt, Janet Ottinger, Victoria Gryszowska, Susan A. Fiscus, R Pat Bucy, and R Pat ACTG 380 Study Team. “Addition of cyclophosphamide to antiretroviral therapy does not diminish the cellular reservoir in HIV-infected persons.” Aids Res Hum Retroviruses 18, no. 8 (May 20, 2002): 535–43. https://doi.org/10.1089/088922202753747888.Full Text Link to Item
-
Szczech, L. A., L. J. Edwards, L. L. Sanders, C. van der Horst, J. A. Bartlett, A. E. Heald, and L. P. Svetkey. “Protease inhibitors are associated with a slowed progression of HIV-related renal diseases.” Clin Nephrol 57, no. 5 (May 2002): 336–41. https://doi.org/10.5414/cnp57336.Full Text Link to Item
-
Wellons, Melissa Fair, Linda Sanders, Lloyd J. Edwards, John A. Bartlett, Alison E. Heald, and Kenneth E. Schmader. “HIV infection: treatment outcomes in older and younger adults.” J Am Geriatr Soc 50, no. 4 (April 2002): 603–7. https://doi.org/10.1046/j.1532-5415.2002.50152.x.Full Text Link to Item
-
Siraj, D. S., J. A. Bartlett, and N. Hyslop. “An infected laceration.” Infections in Medicine 19, no. 2 (March 17, 2002): 63–65.
-
Simpson, David M., Anna-Bettina Haidich, Giovanni Schifitto, Constantin T. Yiannoutsos, Anthony P. Geraci, Justin C. McArthur, David A. Katzenstein, and David A. ACTG 291 study team. “Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels.” Aids 16, no. 3 (February 15, 2002): 407–12. https://doi.org/10.1097/00002030-200202150-00012.Full Text Link to Item
-
Bartlett, J. A. “Addressing the challenges of adherence.” J Acquir Immune Defic Syndr 29 Suppl 1 (February 1, 2002): S2-10. https://doi.org/10.1097/00126334-200202011-00002.Full Text Link to Item
-
Szczech, Lynda Anne, Stephen J. Gange, Charles van der Horst, John A. Bartlett, Mary Young, Mardge H. Cohen, Kathryn Anastos, Preston S. Klassen, and Laura P. Svetkey. “Predictors of proteinuria and renal failure among women with HIV infection.” Kidney Int 61, no. 1 (January 2002): 195–202. https://doi.org/10.1046/j.1523-1755.2002.00094.x.Full Text Link to Item
-
Markert, M. L., A. P. Alvarez-McLeod, G. D. Sempowski, L. P. Hale, J. M. Horvatinovich, K. J. Weinhold, J. A. Bartlett, T. A. D’Amico, and B. F. Haynes. “Thymopoiesis in HIV-infected adults after highly active antiretroviral therapy.” Aids Res Hum Retroviruses 17, no. 17 (November 20, 2001): 1635–43. https://doi.org/10.1089/088922201753342040.Full Text Link to Item
-
Ortiz, G. M., M. Wellons, J. Brancato, H. T. Vo, R. L. Zinn, D. E. Clarkson, K. Van Loon, et al. “Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects.” Proc Natl Acad Sci U S A 98, no. 23 (November 6, 2001): 13288–93. https://doi.org/10.1073/pnas.221452198.Full Text Link to Item
-
Keitz, S. A., T. L. Box, R. K. Homan, J. A. Bartlett, and E. Z. Oddone. “Primary care for patients infected with human immunodeficiency virus: a randomized controlled trial.” J Gen Intern Med 16, no. 9 (September 2001): 573–82. https://doi.org/10.1046/j.1525-1497.2001.016009573.x.Full Text Link to Item
-
Bartlett, J. A., R. DeMasi, J. Quinn, C. Moxham, and F. Rousseau. “Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults.” Aids 15, no. 11 (July 27, 2001): 1369–77. https://doi.org/10.1097/00002030-200107270-00006.Full Text Link to Item
-
Wellons, M. F., J. S. Ottinger, K. J. Weinhold, V. Gryszowka, L. L. Sanders, L. J. Edwards, M. E. Gooding, J. R. Thomasch, and J. A. Bartlett. “Immunologic profile of human immunodeficiency virus-infected patients during viral remission and relapse on antiretroviral therapy.” J Infect Dis 183, no. 10 (May 15, 2001): 1522–25. https://doi.org/10.1086/320193.Full Text Link to Item
-
Nelson, C. G., M. A. Iler, C. W. Woods, J. A. Bartlett, and V. G. Fowler. “Meningococcemia in a patient coinfected with hepatitis C virus and HIV.” Emerg Infect Dis 6, no. 6 (November 2000): 646–48. https://doi.org/10.3201/eid0606.000615.Full Text Open Access Copy Link to Item
-
“Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: a meta-analysis. HIV Surrogate Marker Collaborative Group.” Aids Res Hum Retroviruses 16, no. 12 (August 10, 2000): 1123–33. https://doi.org/10.1089/088922200414965.Full Text Link to Item
-
Markert, M. L., C. B. Hicks, J. A. Bartlett, J. L. Harmon, L. P. Hale, M. L. Greenberg, G. Ferrari, et al. “Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection.” Aids Res Hum Retroviruses 16, no. 5 (March 20, 2000): 403–13. https://doi.org/10.1089/088922200309061.Full Text Link to Item
-
Moore, K. H., G. J. Yuen, E. K. Hussey, G. E. Pakes, J. J. Eron, and J. A. Bartlett. “Population pharmacokinetics of lamivudine in adult human immunodeficiency virus-infected patients enrolled in two phase III clinical trials.” Antimicrob Agents Chemother 43, no. 12 (December 1999): 3025–29. https://doi.org/10.1128/AAC.43.12.3025.Full Text Link to Item
-
Itani, S., and J. A. Bartlett. “Strategies of antiretroviral therapy in adults.” Urol Clin North Am 26, no. 4 (November 1999): 809–x. https://doi.org/10.1016/s0094-0143(05)70221-4.Full Text Link to Item
-
Haynes, B. F., L. P. Hale, K. J. Weinhold, D. D. Patel, H. X. Liao, P. B. Bressler, D. M. Jones, et al. “Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection.” J Clin Invest 103, no. 4 (February 1999): 453–60. https://doi.org/10.1172/JCI5201.Full Text Link to Item
-
Bartlett, J. A., and D. J. Sexton. “Primary care of HIV infection.” Hosp Pract (1995) 33, no. 12 (December 15, 1998): 53–69. https://doi.org/10.3810/hp.1998.12.123.Full Text Link to Item
-
Bartlett, J. A., R. DeMasi, D. Dawson, and A. Hill. “Variability in repeated consecutive measurements of plasma human immunodeficiency virus RNA in persons receiving stable nucleoside reverse transcriptase inhibitor therapy or no treatment.” J Infect Dis 178, no. 6 (December 1998): 1803–5. https://doi.org/10.1086/314503.Full Text Link to Item
-
Bartlett, J. A., C. Berend, G. R. Petroni, J. Ottinger, D. L. Tyler, C. Pettinelli, and K. J. Weinhold. “Coadministration of zidovudine and interleukin-2 increases absolute CD4 cells in subjects with Walter Reed stage 2 human immunodeficiency virus infection: results of ACTG protocol 042.” J Infect Dis 178, no. 4 (October 1998): 1170–73. https://doi.org/10.1086/515677.Full Text Link to Item
-
Tyler, D. S., S. D. Stanley, J. A. Bartlett, D. P. Bolognesi, and K. J. Weinhold. “Lymphokine-activated killer (LAK) cell anti-HIV-1 ADCC reactivity: a potential strategy for reduction of virus-infected cellular reservoirs.” J Surg Res 79, no. 2 (October 1998): 115–20. https://doi.org/10.1006/jsre.1998.5415.Full Text Link to Item
-
Bartlett, J. A., S. S. Wasserman, C. B. Hicks, R. T. Dodge, K. J. Weinhold, C. O. Tacket, N. Ketter, A. E. Wittek, T. J. Palker, and B. F. Haynes. “Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research Initiative.” Aids 12, no. 11 (July 30, 1998): 1291–1300. https://doi.org/10.1097/00002030-199811000-00010.Full Text Link to Item
-
Bartlett, J. A. “Strategies of Antiretroviral Therapy in Adults.” Oncologist 3, no. 2 (1998): 111–18.Link to Item
-
Bartlett, J. A., P. S. Berry, K. W. Bockman, A. Stein, J. Johnson, S. Graham, J. Quinn, R. DeMasi, and W. J. Alexander. “A placebo-controlled trial of ranitidine in patients with early human immunodeficiency virus infection.” J Infect Dis 177, no. 1 (January 1998): 231–34. https://doi.org/10.1086/517361.Full Text Link to Item
-
Hecht, F. M., J. Wheat, A. H. Korzun, R. Hafner, K. J. Skahan, R. Larsen, M. T. Limjoco, et al. “Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trial.” J Acquir Immune Defic Syndr Hum Retrovirol 16, no. 2 (October 1, 1997): 100–107. https://doi.org/10.1097/00042560-199710010-00005.Full Text Link to Item
-
Ferrari, G., C. Berend, J. Ottinger, R. Dodge, J. Bartlett, J. Toso, D. Moody, et al. “Replication-defective canarypox (ALVAC) vectors effectively activate anti-human immunodeficiency virus-1 cytotoxic T lymphocytes present in infected patients: implications for antigen-specific immunotherapy.” Blood 90, no. 6 (September 15, 1997): 2406–16.Link to Item
-
Bartlett, J. A., and C. Hulette. “Central nervous system pneumocystosis in a patient with AIDS.” Clin Infect Dis 25, no. 1 (July 1997): 82–85. https://doi.org/10.1086/514519.Full Text Link to Item
-
Staszewski, S., A. M. Hill, J. Bartlett, J. J. Eron, C. Katlama, J. Johnson, W. Sawyer, and H. McDade. “Reductions in HIV-1 disease progression for zidovudine/lamivudine relative to control treatments: a meta-analysis of controlled trials.” Aids 11, no. 4 (March 15, 1997): 477–83. https://doi.org/10.1097/00002030-199704000-00011.Full Text Link to Item
-
Phillips, A. N., J. Eron, J. Bartlett, D. R. Kuritzkes, V. A. Johnson, C. Gilbert, J. Johnson, A. Keller, and A. M. Hill. “Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals. North American Lamivudine HIV Working Group.” Aids 11, no. 2 (February 1997): 169–75. https://doi.org/10.1097/00002030-199702000-00006.Full Text Link to Item
-
Riddler, S. A., L. H. Wang, J. A. Bartlett, P. M. Savina, M. V. Packard, D. K. McMahon, M. R. Blum, J. A. Dunn, M. M. Elkins, and J. W. Mellors. “Safety and pharmacokinetics of 5-chloro-2',3'-dideoxy-3'-fluorouridine (935U83) following oral administration of escalating single doses in human immunodeficiency virus-infected adults.” Antimicrob Agents Chemother 40, no. 12 (December 1996): 2842–47. https://doi.org/10.1128/AAC.40.12.2842.Full Text Link to Item
-
Gottfredsson, M., T. D. Oury, C. Bernstein, C. Carpenter, and J. A. Bartlett. “Lymphoma of the pituitary gland: an unusual presentation of central nervous system lymphoma in AIDS.” Am J Med 101, no. 5 (November 1996): 563–64. https://doi.org/10.1016/s0002-9343(96)00257-4.Full Text Link to Item
-
Bartlett, J. A., S. L. Benoit, V. A. Johnson, J. B. Quinn, G. E. Sepulveda, W. C. Ehmann, C. Tsoukas, M. A. Fallon, P. L. Self, and M. Rubin. “Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection. A randomized, double-blind, placebo-controlled trial. North American HIV Working Party.” Ann Intern Med 125, no. 3 (August 1, 1996): 161–72. https://doi.org/10.7326/0003-4819-125-3-199608010-00001.Full Text Link to Item
-
Heald, A. E., J. M. Hoffman, J. A. Bartlett, and H. A. Waskin. “Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET).” Int J Std Aids 7, no. 5 (August 1996): 337–46. https://doi.org/10.1258/0956462961918239.Full Text Link to Item
-
Phillips, A. N., J. J. Eron, J. A. Bartlett, M. Rubin, J. Johnson, S. Price, P. Self, and A. M. Hill. “HIV-1 RNA levels and the development of clinical disease. North American Lamivudine HIV Working Group.” Aids 10, no. 8 (July 1996): 859–65. https://doi.org/10.1097/00002030-199607000-00009.Full Text Link to Item
-
Heald, A. E., P. H. Hsyu, G. J. Yuen, P. Robinson, P. Mydlow, and J. A. Bartlett. “Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction.” Antimicrob Agents Chemother 40, no. 6 (June 1996): 1514–19. https://doi.org/10.1128/AAC.40.6.1514.Full Text Link to Item
-
Cohen, O. J., G. Pantaleo, M. Holodniy, C. H. Fox, J. M. Orenstein, S. Schnittman, M. Niu, et al. “Antiretroviral monotherapy in early stage human immunodeficiency virus disease has no detectable effect on virus load in peripheral blood and lymph nodes.” J Infect Dis 173, no. 4 (April 1996): 849–56. https://doi.org/10.1093/infdis/173.4.849.Full Text Link to Item
-
Heald, A. E., G. M. Cox, W. A. Schell, J. A. Bartlett, and J. R. Perfect. “Oropharyngeal yeast flora and fluconazole resistance in HIV-infected patients receiving long-term continuous versus intermittent fluconazole therapy.” Aids 10, no. 3 (March 1996): 263–68. https://doi.org/10.1097/00002030-199603000-00004.Full Text Link to Item
-
Harbin, H. T., A. Shusterman, I. Shaffer, and J. Bartlett. “Health reform in the private sector: initiatives of the American Managed Behavioral Healthcare Association.” Behav Healthc Tomorrow 4, no. 5 (September 1995): 37–39.Link to Item
-
Ferrari, G., K. King, K. Rathbun, C. A. Place, M. V. Packard, J. A. Bartlett, D. P. Bolognesi, and K. J. Weinhold. “IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp).” Clin Exp Immunol 101, no. 2 (August 1995): 239–48. https://doi.org/10.1111/j.1365-2249.1995.tb08345.x.Full Text Link to Item
-
Graham, C. S., B. G. Graham, J. A. Bartlett, A. E. Heald, and S. S. Schiffman. “Taste and smell losses in HIV infected patients.” Physiol Behav 58, no. 2 (August 1995): 287–93. https://doi.org/10.1016/0031-9384(95)00049-o.Full Text Link to Item
- Link to Item
-
Jacobson, M. A., V. De Gruttola, M. Reddy, J. M. Arduino, S. Strickland, R. C. Reichman, J. A. Bartlett, J. P. Phair, M. S. Hirsch, and A. C. Collier. “The predictive value of changes in serologic and cell markers of HIV activity for subsequent clinical outcome in patients with asymptomatic HIV disease treated with zidovudine.” Aids 9, no. 7 (July 1995): 727–34. https://doi.org/10.1097/00002030-199507000-00010.Full Text Link to Item
-
Cohen, O. J., G. Pantaleo, M. Holodniy, S. Schnittman, M. Niu, C. Graziosi, G. N. Pavlakis, J. Lalezari, J. A. Bartlett, and R. T. Steigbigel. “Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue.” Proc Natl Acad Sci U S A 92, no. 13 (June 20, 1995): 6017–21. https://doi.org/10.1073/pnas.92.13.6017.Full Text Link to Item
-
Wheat, J., R. Hafner, A. H. Korzun, M. T. Limjoco, P. Spencer, R. A. Larsen, F. M. Hecht, and W. Powderly. “Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group.” Am J Med 98, no. 4 (April 1995): 336–42. https://doi.org/10.1016/s0002-9343(99)80311-8.Full Text Link to Item
-
Bartlett, J. “Herpes virus infections, HIV, and disease progression. Guarded optimism.” Aids Clin Care 7, no. 2 (February 1995): 15.Link to Item
-
Keitz, S. A., and J. A. Bartlett. “Facing the challenge of HIV. Primary care physicians have an obligation to care for those infected.” N C Med J 55, no. 10 (October 1994): 468–70.Link to Item
-
Heald, A. E., and J. A. Bartlett. “Cryptosporidium spread in a group residential home.” Ann Intern Med 121, no. 6 (September 15, 1994): 467–68. https://doi.org/10.7326/0003-4819-121-6-199409150-00015.Full Text Link to Item
-
May, D. B., R. H. Drew, K. C. Yedinak, and J. A. Bartlett. “Effect of simultaneous didanosine administration on itraconazole absorption in healthy volunteers.” Pharmacotherapy 14, no. 5 (September 1994): 509–13.Link to Item
-
Volberding, P. A., S. W. Lagakos, J. M. Grimes, D. S. Stein, H. H. Balfour, R. C. Reichman, J. A. Bartlett, M. S. Hirsch, J. P. Phair, and R. T. Mitsuyasu. “The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.” Jama 272, no. 6 (August 10, 1994): 437–42.Link to Item
-
Bartlett, J. A. “Early versus delayed zidovudine in the management of HIV infection.” Expert Opinion on Investigational Drugs 3, no. 8 (August 1, 1994): 809–19. https://doi.org/10.1517/13543784.3.8.809.Full Text
-
Goodwin, S. D., H. A. Gallis, A. T. Chow, F. A. Wong, S. C. Flor, and J. A. Bartlett. “Pharmacokinetics and safety of levofloxacin in patients with human immunodeficiency virus infection.” Antimicrob Agents Chemother 38, no. 4 (April 1994): 799–804. https://doi.org/10.1128/aac.38.4.799.Full Text Link to Item
-
Cameron, M. L., W. A. Schell, S. Bruch, J. A. Bartlett, H. A. Waskin, and J. R. Perfect. “Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1.” Antimicrob Agents Chemother 37, no. 11 (November 1993): 2449–53. https://doi.org/10.1128/aac.37.11.2449.Full Text Link to Item
-
Chen, C. H., K. J. Weinhold, J. A. Bartlett, D. P. Bolognesi, and M. L. Greenberg. “CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism.” Aids Res Hum Retroviruses 9, no. 11 (November 1993): 1079–86. https://doi.org/10.1089/aid.1993.9.1079.Full Text Link to Item
-
Myers, S. A., N. S. Prose, and J. A. Bartlett. “Progress in the understanding of HIV infection: an overview.” J Am Acad Dermatol 29, no. 1 (July 1993): 1–21. https://doi.org/10.1016/0190-9622(93)70146-k.Full Text Link to Item
-
Chen, C. H., K. J. Weinhold, J. A. Bartlett, D. P. Bolognesi, and M. L. Greenberg. “CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: A novel antiviral mechanism.” Aids Research and Human Retroviruses 9, no. 11 (1993): 1079–86.
-
Shaunak, S., R. E. Albright, and J. A. Bartlett. “Amplification of human immunodeficiency virus provirus from cerebrospinal fluid: results of long-term clinical follow-up.” J Infect Dis 164, no. 4 (October 1991): 818. https://doi.org/10.1093/infdis/164.4.818.Full Text Link to Item
-
Shadduck, P. P., J. B. Weinberg, A. F. Haney, J. A. Bartlett, A. J. Langlois, D. P. Bolognesi, and T. J. Matthews. “Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of human blood monocytes and peritoneal macrophages.” J Virol 65, no. 8 (August 1991): 4309–16. https://doi.org/10.1128/JVI.65.8.4309-4316.1991.Full Text Link to Item
-
Stine, K. C., D. S. Tyler, S. D. Stanley, J. A. Bartlett, D. P. Bolognesi, and K. J. Weinhold. “The effect of AZT on in vitro lymphokine-activated killer (LAK) activity in human immunodeficiency virus type-1 (HIV-1) infected individuals.” Cell Immunol 136, no. 1 (August 1991): 165–72. https://doi.org/10.1016/0008-8749(91)90391-n.Full Text Link to Item
-
Hersh, E. M., G. Brewton, D. Abrams, J. Bartlett, J. Galpin, P. Gill, R. Gorter, M. Gottlieb, J. J. Jonikas, and S. Landesman. “Ditiocarb sodium (diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS. A randomized, double-blind, placebo-controlled, multicenter study.” Jama 265, no. 12 (March 27, 1991): 1538–44.Link to Item
-
Cameron, M. L., J. A. Bartlett, H. A. Gallis, and H. A. Waskin. “Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome.” Rev Infect Dis 13, no. 1 (January 1991): 64–67. https://doi.org/10.1093/clinids/13.1.64.Full Text Link to Item
-
Easterbrook, P. J., J. C. Keruly, T. Creagh-Kirk, D. D. Richman, R. E. Chaisson, R. D. Moore, J. Bartlett, et al. “Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease.” Journal of the American Medical Association 266, no. 19 (1991): 2713–18. https://doi.org/10.1001/jama.266.19.2713.Full Text
-
Bartlett, J. A. “Current and future treatment of HIV infection.” Oncology (Williston Park) 4, no. 11 (November 1990): 19–29.Link to Item
-
Ingram, C. W., and J. A. Bartlett. “Simultaneous pneumococcal and Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome.” South Med J 83, no. 10 (October 1990): 1215–17. https://doi.org/10.1097/00007611-199010000-00021.Full Text Link to Item
-
Shaunak, S., R. E. Albright, M. E. Klotman, S. C. Henry, J. A. Bartlett, and J. D. Hamilton. “Amplification of HIV-1 provirus from cerebrospinal fluid and its correlation with neurologic disease.” J Infect Dis 161, no. 6 (June 1990): 1068–72. https://doi.org/10.1093/infdis/161.6.1068.Full Text Link to Item
-
Tyler, D. S., S. D. Stanley, C. A. Nastala, A. A. Austin, J. A. Bartlett, K. C. Stine, H. K. Lyerly, D. P. Bolognesi, and K. J. Weinhold. “Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.” J Immunol 144, no. 9 (May 1, 1990): 3375–84.Link to Item
-
Volberding, P. A., S. W. Lagakos, M. A. Koch, C. Pettinelli, M. W. Myers, D. K. Booth, H. H. Balfour, R. C. Reichman, J. A. Bartlett, and M. S. Hirsch. “Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.” N Engl J Med 322, no. 14 (April 5, 1990): 941–49. https://doi.org/10.1056/NEJM199004053221401.Full Text Link to Item
-
Bartlett, J. A. “HIV testing in North Carolina.” N C Med J 51, no. 4 (April 1990): 150–51.Link to Item
-
Tyler, D. S., S. Shaunak, J. A. Bartlett, and J. D. Iglehart. “HIV-1-associated thrombocytopenia. The role of splenectomy.” Ann Surg 211, no. 2 (February 1990): 211–17. https://doi.org/10.1097/00000658-199002000-00014.Full Text Link to Item
-
Telen, M. J., K. B. Roberts, and J. A. Bartlett. “HIV-associated autoimmune hemolytic anemia: report of a case and review of the literature.” J Acquir Immune Defic Syndr (1988) 3, no. 10 (1990): 933–37.Link to Item
-
Drew, R. H., S. Weller, H. A. Gallis, K. A. Walmer, J. A. Bartlett, and M. R. Blum. “Bioequivalence assessment of zidovudine (Retrovir) syrup, solution, and capsule formulations in patients infected with human immunodeficiency virus.” Antimicrob Agents Chemother 33, no. 10 (October 1989): 1801–3. https://doi.org/10.1128/aac.33.10.1801.Full Text Link to Item
-
Shaunak, S., and J. A. Bartlett. “Zidovudine-induced neutropenia: are we too cautious?” Lancet 2, no. 8654 (July 8, 1989): 91–92. https://doi.org/10.1016/s0140-6736(89)90325-5.Full Text Link to Item
-
Wiener, J. R., J. A. Bartlett, and W. K. Joklik. “The sequences of reovirus serotype 3 genome segments M1 and M3 encoding the minor protein mu 2 and the major nonstructural protein mu NS, respectively.” Virology 169, no. 2 (April 1989): 293–304. https://doi.org/10.1016/0042-6822(89)90154-2.Full Text Link to Item
-
Bartlett, J. A. “HIV therapeutics: an emerging science.” Jama 260, no. 20 (November 25, 1988): 3051–52.Link to Item
-
Bartlett, J. A., and W. K. Joklik. “The sequence of the reovirus serotype 3 L3 genome segment which encodes the major core protein lambda 1.” Virology 167, no. 1 (November 1988): 31–37. https://doi.org/10.1016/0042-6822(88)90051-7.Full Text Link to Item
-
Keller, S. E., S. J. Schleifer, J. A. Bartlett, and R. L. Johnson. “The sexual behavior of adolescents and risk of AIDS.” Journal of the American Medical Association 260, no. 24 (1988): 3586-.
-
Cohen, J. I., J. A. Bartlett, and G. R. Corey. “Extra-intestinal manifestations of salmonella infections.” Medicine (Baltimore) 66, no. 5 (September 1987): 349–88. https://doi.org/10.1097/00005792-198709000-00003.Full Text Link to Item
-
-
Book Sections
-
Moon, A. M., and J. A. Bartlett. “HIV infection and AIDS.” In Men’s Health, Third Edition, 252–72, 2009.
-
-
Other Articles
-
Haynes, B. F., L. P. Hale, K. J. Weinhold, D. D. Patel, H. X. Liao, P. B. Bressler, D. M. Jones, et al. “Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection.” J Clin Invest, March 15, 1999. https://doi.org/10.1172/jci5201e1.Full Text Link to Item
-
-
Journal Issues
-
Paul, Devon W., Nigel B. Neely, Meredith Clement, Isaretta Riley, Mashael Al-Hegelan, Matthew Phelan, Monica Kraft, et al. “Development and validation of an electronic medical record (EMR)-based computed phenotype of HIV-1 infection.” J Am Med Inform Assoc, February 1, 2018. https://doi.org/10.1093/jamia/ocx061.Full Text Link to Item
-
-
Conference Papers
-
Tyler, D. S., S. D. Stanley, E. A. Bumpas, J. A. Bartlett, D. P. Bolognesi, and K. J. Weinhold. “The antiretroviral effects of lymphokine-activated killer cells.” In Surgical Forum, 40:435–37, 1989.
-
-
- Scholarly, Clinical, & Service Activities
-
Outreach & Engaged Scholarship
- Global Health Outreach. Developing a Regional Cancer Registry in Kilimanjaro, Tanzania. Kilimanjaro Christian Medical Center . July 2017 2017
- Global Health Outreach. International Maternal Pediatric Adolescent AIDS Clinical Trials. Kilimanjaro Christian Medical Center . April 2014 2014
- Global Health Outreach. Development of Sociobehavioral Sciences Research Capacity in Tanzania. August 2013 2013
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.
